HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Treatment of stage I nonseminomatous testicular cancer with one cycle of adjuvant chemotherapy].

Abstract
On May 1990, we began a treatment protocol for testicular stage I nonseminomatous cancer, with one chemotherapy cycle consisting of a cisplatin based combination of drugs. Until July 1996 we had admitted 18 patients, presenting five of them embryonal carcinoma and three yolk sac tumors. So far, with a median follow-up of 46.9 months, we had not relapses. 11 patients have normal long term semen analysis, with two achieving pregnancy. We believe this is acceptable alternative for treating stage I nonseminomatous cancer with scarce drugs adverse reactions. The convenience of selecting patients previous admittance, is discussed.
AuthorsD Corti Ortíz, A Fonerón Burgos, L Troncoso Schifferli
JournalActas urologicas espanolas (Actas Urol Esp) 1997 Nov-Dec Vol. 21 Issue 10 Pg. 961-3 ISSN: 0210-4806 [Print] Spain
Vernacular TitleTratamiento del cáncer testicular no seminoma etapa I con un ciclo de quimioterapia adyuvante.
PMID9494159 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Bleomycin
  • Vinblastine
  • Cisplatin
Topics
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Bleomycin (administration & dosage)
  • Carcinoma, Embryonal (drug therapy, pathology)
  • Chemotherapy, Adjuvant
  • Cisplatin (administration & dosage)
  • Endodermal Sinus Tumor (drug therapy, pathology)
  • Humans
  • Male
  • Neoplasm Staging
  • Neoplasms, Germ Cell and Embryonal (drug therapy, pathology)
  • Testicular Neoplasms (drug therapy, pathology)
  • Vinblastine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: